Navigation Links
New Thomson Reuters Biomarkers Report Shines a Light on Revolutionary New Area of Drug Development
Date:4/29/2008

Biomarkers to Open the Door to Personalized Medicine and Represents a

Seismic Shift for the Pharma Industry

PHILADELPHIA and LONDON, April 29 /PRNewswire-FirstCall/ -- The Scientific business of Thomson Reuters today announced the launch of a new biomarkers report, "Establishing the Standards in Biomarker Research" which gives a detailed introduction to the world of biomarkers, an overview of the regulatory context surrounding them, and highlights ongoing biomarker research in some of the world's leading Pharma companies.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080424/NYTH069LOGO )

Thomson Reuters has chosen to highlight advances in biomarker research because of its capacity to change the way Pharma companies do business. Biomarkers which are blood-based tests, gene sequences or mutations, mRNA expression profiles or tissue proteins, provide unparalleled evidence of the state of an organism, or indicate normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention.

"Biomarkers seem destined to prove one of the major drivers of pharmaceutical research and drug development in the 21st century," said Jon Brett-Harris, EVP Pharmaceutical and Chemicals Markets, Thomson Reuters. "For example, the presence of a specific antibody in the blood might indicate a specific infection. Once an association between a biomarker and a disease is clearly established, the one can be used to signal the other, and to a high degree of certainty. As well, changes in the prevalence of a biomarker in the organism can immediately and reliably signpost a patient's response to treatment."

Some pharmaceutical companies are already advancing their research and harnessing the power of biomarkers, which can:
-- Be used to detect the predisposition for disease in a population,

screen
'/>"/>

SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Thomson Healthcare Undertakes Medical Staff Development Project for IASIS Healthcare
2. Thomson Scientific To Honor Australias Top Researchers With Dedicated Australian Research Day
3. Thomson Healthcare Announces Enhancements to Order Sets Solution
4. Thomson Healthcares Clinical Xpert Navigator Tops KLAS Annual Performance Ranking in Mobile Data Systems for Sixth Consecutive Year
5. Thomson Scientific Introduces a New Quarterly Report Identifying the Movers and Shakers in the U.S. Generics Industry
6. Jobson Medical Information LLC Acquires CenterWatch and New England IRB From Thomson Healthcare
7. Saint Barnabas Health Care System Expands Business Relationship with Thomson Healthcare
8. Protalix BioTherapeutics prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific
9. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
10. Thomson Scientific Takes a Fresh Look at Multiauthor Papers
11. Thomson Healthcare Study Finds That Hospitals Delivering High-Quality Heart Care Are Efficient and Cost Effective, Too
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... ... Day at the Zoo to celebrate children helping children, a thank you to ... throughout West Ohio have contributed to the United Methodist initiative to end malaria ...
(Date:8/28/2015)... Angeles, CA (PRWEB) , ... August 28, 2015 , ... ... endless journey that local pizza maker Paul LaRocco has gone through to open a ... city approval and permitting process tends to take several months, but the current process, ...
(Date:8/28/2015)... ... 28, 2015 , ... For Dallas, the time is nearing for the annual ... Tenet Health. , The American Heart Association hosts their well-known Heart Walk to raise ... together, a difference can be made. Walkers can participate in the cause and someone ...
(Date:8/28/2015)... ... 2015 , ... As reported by Medical Daily on August 22 , ... that last for two years, the longest of any cellulite reduction system currently on ... a long-lasting, effective solution for their cellulite, according to Dr. Robert Weiss, director of ...
(Date:8/28/2015)... ... August 28, 2015 , ... On May 30th, 2015, Best Drug Rehabilitation, a ... “Music With A Mission” benefit concert in Mendon, IL. Held in the Show Barn ... to support music education programs in the underfunded local school districts of Mendon at ...
Breaking Medicine News(10 mins):Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2
... Beth Israel Deaconess,Medical Center audit, BOSTON, Feb. 6 ... apply the same Sarbanes-Oxley,standards used by Boston Properties and ... of Beth Israel Deaconess Medical Center (BIDMC),according to labor ... the president and CFO of Boston Properties., 1199 ...
... The Female Health Company,(Amex: FHC ) today ... call,to discuss its operating results for the first ... on Wednesday, February 13, 2008. The Company plans,to ... the same day., Shareholders and other interested ...
... asks board member to seek restatement of Beth Israel ... Automation CEO and,director Robert Lepofsky should apply the same ... to his role as Vice,Chairperson of the board of ... (BIDMC), according to labor group 1199 SEIU,United Healthcare Workers ...
... TULSA, Okla., Feb. 6 It takes a team ... That,s the,message of an event scheduled for 10 a.m. ... a significant improvement in Oklahoma,s rates of,early childhood immunizations., ... based on,data from 2005 and 2006, the state improved ...
... Limited, BOSTON, Feb. 6 Patient-Centered Computing,and eHealth: ... will be presented under the auspices of Harvard Medical,School,s ... held,at the Omni Parker House Hotel in Boston, MA ... 2006 event that attracted 120 attendees from,throughout the United ...
... This release is also available in German . ... giant dinosaurs could have lived off more than 100 million years ... to become as large as they did. In actual fact such ... have now been published in the journal ,Proceedings of the Royal ...
Cached Medicine News:Health News:Boston Properties Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:The Female Health Company Schedules First Quarter Conference Call for February 13, 2008 2Health News:Brooks Automation Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:State Leaders Recognize Oklahoma's Improvement in Immunization Rankings 2Health News:Innovative eHealth Course to Take Place March 28-30 in Boston, Massachusetts 2Health News:Bonn scientists simulate dinosaur digestion in the lab 2Health News:Bonn scientists simulate dinosaur digestion in the lab 3
(Date:8/28/2015)... Aug. 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... completed the acquisition of leading OTC brands from GSK ... The transaction is a clear demonstration of Perrigo,s unique ... European distribution network spanning 36 countries.  ... commented, "We are excited to complete this transaction, ...
(Date:8/28/2015)... Aug. 28, 2015 , Joint ... Ra from Biostar , Published in ,Stem Cells ... of lifespan through multiple IV administration of Adipose-derived MSC ... life expectancy found , Commercialization within 5 years ... the possibility that adult mesenchymal stem cells (MSCs) may ...
(Date:8/28/2015)... LONDON , August 28, 2015 ... approach seamlessly connects people, technologies and care ... improving outcomes and the cost of healthcare delivery ... AEX: PHIA) today announced its presence at  ESC Congress 2015 , ... Heart Model A.I. , EchoNavigator and IntelliSpace Cardiovascular, that connect ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4
... Ridge Diagnostics, Inc., a neurodiagnostic company, announced that ... test for Major Depressive Disorder(MDD), will be presented during ... to Aid in Diagnosis, Treatment and Management of Major ... Meeting, May 20, 2009. The blood test, for the ...
... ATLANTA, May 20 /PRNewswire-FirstCall/ -- ... an Atlanta-based, publicly traded biopharmaceutical company developing human ... Virus) and other infectious agents, announced today that ... band Styx, has joined the GeoVax Labs awareness ...
Cached Medicine Technology:Ridge Diagnostics, Inc. Clinical Data on Blood Test for Depression Presented at American Psychiatric Association Annual Meeting 2Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine 2Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine 3Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine 4